Related Experiment Video
Updated: Jun 9, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Cardiac Troponin Levels in Patients with Chronic Kidney Disease: "Markers of High Risk or Just Noise''?
Eleni V Geladari1, Natalia G Vallianou2, Angelos Evangelopoulos3
1Department of Internal Medicine, Evangelismos General Hospital, 45-47 Ipsilantou Str., 10676 Athens, Greece.
Insights
Chronic kidney disease (CKD) patients often show elevated cardiac troponins (cTnT and cTnI), which can be confusing. This review clarifies why CKD causes high troponin levels and when intervention is needed.
Area of Science:
- Cardiology
- Nephrology
- Biomarker Research
Background:
- Cardiovascular disorders are a major cause of mortality in patients with kidney disease.
- Early detection of myocardial damage is crucial for managing cardiovascular complications in this high-risk group.
- Cardiac troponins (cTnT and cTnI) are established biomarkers for myocardial injury and acute myocardial infarction.
Purpose of the Study:
- To explore the underlying reasons for elevated troponin levels in patients with chronic kidney disease.
- To provide guidance on interpreting elevated troponin levels in CKD patients.
- To determine when elevated troponin levels in CKD necessitate urgent clinical intervention.
Main Methods:
- Review of existing literature on cardiac troponin levels in chronic kidney disease.
- Analysis of factors contributing to myocardial damage and troponin elevation in CKD.
- Clinical interpretation of elevated troponin values in the context of cardiovascular risk in CKD.
Main Results:
- Elevated cardiac troponin (cTnT and cTnI) levels are frequently observed in asymptomatic patients with chronic kidney disease.
- These elevations can stem from various factors related to CKD, not solely acute myocardial infarction.
- Distinguishing between CKD-related elevations and true cardiac events is clinically challenging.
Conclusions:
- Elevated troponins in CKD patients require careful interpretation due to potential non-ischemic causes.
- Understanding the specific context of CKD is vital for appropriate clinical decision-making.
- Further research is needed to refine the diagnostic and prognostic utility of troponins in CKD.
Abstract:
Kidney disease is linked to the development of cardiovascular disorders, further increasing morbidity and mortality in this high-risk population. Thus, early detection of myocardial damage is imperative in order to prevent devastating cardiovascular complications within this patient group. Over the years, cardiac biomarkers have been identified and are now widely used in everyday clinical practice. More specifically, available data suggest that cardiac troponin and its regulatory subunits (TnT, TnI, and TnC) reflect the injury and necrosis of myocardial tissue. While cTnC is identical in cardiac and skeletal muscle, TnT and TnI constitute cardiac-specific forms of troponin, and, as such, they have been established by international societies as biomarkers of cardiac damage and diagnostic indicators for acute myocardial infarction. Elevations in the levels of both cardiac troponins (cTnT and cTnI) have been also reported in asymptomatic patients suffering from chronic kidney disease. Therefore, if abnormal, they often generate confusion among clinicians regarding the interpretation and clinical significance of their numerical values in emergency settings. The aim of this review is to explore the reasons behind elevated troponin levels in patients with chronic kidney disease and identify when these elevated levels of biomarkers indicate the need for urgent intervention, considering the high cardiovascular risk in this patient group.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Acute Coronary Syndrome III: Diagnostic studies
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Nephrons

